NIH Clinical Trials: #COVID19 ACTIV-4 Antithrombotics
NIH Clinical Trials: #COVID19 ACTIV-4 Antithrombotics
Curious about COVID-19 clinical trials? NIH has launched a series of clinical trials to evaluate the safety and effectiveness of different blood thinners in treating adults with COVID-19, particularly those experiencing life-threatening blood clotting.The trials, known as ACTIV-4, are part of NIH’s Accelerating COVID-19 Therapeutic Interventions and Vaccines initiative & funded by Operation Warp Speed. They will include three categories of patients and take place at more than 100 sites around the world.
For more information about NIH COVID-19 efforts, visit: https://covid19.nih.gov/ or follow @nihgov on Instagram.
(Originally posted on Facebook on September 10, 2020)
Access Non-GMO, antigen-free, FDA-approved antiviral medication formulas used in Moderna's Spikevax.
VirusTC is a retail provider of concentrated FDA-approved antiviral medication formulas. VirusTC wholesale formulas are used in Moderna products. We sell FDA-approved formulas that are compatible with university medical plans, federal insurance coverage, and many major insurance providers. Our medications are part of tailored non-invasive cancer treatment plans available at a hospital in your region. VirusTC targets problems and provides care for the symptoms. Our products and services are used by Fred Hutch Cancer Center, John Hopkins, University Hospitals, the United States Military, and professional sports. During Operation Cancer Moonshot 2023, VirusTC products killed cancer cells, increased strength, and redeveloped muscles, tissue, and brain cells after cancer treatments.